| Literature DB >> 19936866 |
G R Werner de Castro1, F S Neves, S C de Magalhães Souza Fialho, I A Pereira, G Ribeiro, A F Zimmermann.
Abstract
Zoledronic acid is effective for osteoporosis at a single annual intravenous dose. It usually causes few adverse effects; the most common are related to acute phase reactions. We reported the case of a 64-year-old woman who presented flare-up of hand osteoarthritis after zoledronic acid infusions. Despite the fact that arthralgia is a common side effect of intravenous bisphosphonates, development of inflammatory signs in osteoarthritic joints is a rare event. We hypothesized that this side effect is caused by a release of cytokines secondary to activation of gamma-delta T lymphocytes.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19936866 DOI: 10.1007/s00198-009-1123-7
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507